DD157561A5 - Verfahren zur herstellung von mucopolysacchariden - Google Patents

Verfahren zur herstellung von mucopolysacchariden Download PDF

Info

Publication number
DD157561A5
DD157561A5 DD81228490A DD22849081A DD157561A5 DD 157561 A5 DD157561 A5 DD 157561A5 DD 81228490 A DD81228490 A DD 81228490A DD 22849081 A DD22849081 A DD 22849081A DD 157561 A5 DD157561 A5 DD 157561A5
Authority
DD
German Democratic Republic
Prior art keywords
heparin
acid
products
anhydro
groups
Prior art date
Application number
DD81228490A
Other languages
German (de)
English (en)
Inventor
Jean-Claude Lormeau
Maurice Petitou
Jean Choay
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9239907&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD157561(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choay Sa filed Critical Choay Sa
Publication of DD157561A5 publication Critical patent/DD157561A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DD81228490A 1980-03-20 1981-03-20 Verfahren zur herstellung von mucopolysacchariden DD157561A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8006282A FR2478646A2 (fr) 1980-03-20 1980-03-20 Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir

Publications (1)

Publication Number Publication Date
DD157561A5 true DD157561A5 (de) 1982-11-17

Family

ID=9239907

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81228490A DD157561A5 (de) 1980-03-20 1981-03-20 Verfahren zur herstellung von mucopolysacchariden

Country Status (20)

Country Link
US (1) US4686288A (cs)
EP (1) EP0037319B2 (cs)
JP (1) JPH0231081B2 (cs)
AR (1) AR227417A1 (cs)
AT (1) ATE26450T1 (cs)
CA (1) CA1207759A (cs)
CS (1) CS222245B2 (cs)
DD (1) DD157561A5 (cs)
DE (1) DE3176086D1 (cs)
DK (1) DK172877B1 (cs)
ES (1) ES501130A0 (cs)
FR (1) FR2478646A2 (cs)
HU (1) HU188657B (cs)
IE (1) IE52951B1 (cs)
IL (1) IL62424A (cs)
PL (1) PL135948B1 (cs)
SU (1) SU1658820A3 (cs)
UA (1) UA5934A1 (cs)
WO (1) WO1981002737A1 (cs)
YU (1) YU43008B (cs)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
FR2553287B1 (fr) * 1983-10-18 1986-09-12 Choay Sa Compositions a base de mucopolysaccharides ou d'oligosaccharides, notamment a base de fractions ou fragments d'heparine, appropriees au traitement de desordres de la proliferation cellulaire
CA1260461A (fr) * 1984-10-18 1989-09-26 Jean-Claude Lormeau Procede de preparation de compositions de mucopolysaccharides dotes d'une activite antithrombotique elevee
FR2572080B1 (fr) * 1984-10-18 1987-06-26 Dropic Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee, les compositions obtenues et leur application en tant que medicaments
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
IT1230582B (it) 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
JP2871822B2 (ja) * 1989-08-29 1999-03-17 玉造株式会社 末端に２，５―アンヒドロマンニトール基または２，５―アンヒドロマンノース基を有するキチン・キトサンオリゴマーおよびその製造方法
WO1991015216A1 (en) * 1990-04-05 1991-10-17 Kennedy Thomas P Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
FR2691066B1 (fr) * 1992-05-15 1995-06-09 Sanofi Elf Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
DE4217917A1 (de) * 1992-05-30 1993-12-02 Job Prof Dr Med Harenberg Immobilisation von chemisch kovalent gebundenem Heparin an Polymere mit Arylresten im Polymer
JP3390477B2 (ja) * 1993-01-25 2003-03-24 生化学工業株式会社 薬剤組成物及びその製造法
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
AU754936B2 (en) * 1996-11-27 2002-11-28 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
US5945457A (en) * 1997-10-01 1999-08-31 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science Process for preparing biologically compatible polymers and their use in medical devices
DE29900874U1 (de) 1999-01-20 1999-07-22 Knoll Ag Organprotektive Lösungen
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7575886B2 (en) * 2002-03-11 2009-08-18 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7956046B2 (en) 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
KR101529061B1 (ko) 2008-05-30 2015-06-16 모멘타 파머슈티컬스 인코포레이티드 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법
WO2011090948A1 (en) * 2010-01-19 2011-07-28 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
FR2440376A1 (fr) * 1978-11-06 1980-05-30 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
GB2071127B (en) * 1980-02-29 1984-07-25 Italfarmaco Spa Process for the purification of glucosaninoglucans
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity

Also Published As

Publication number Publication date
ATE26450T1 (de) 1987-04-15
EP0037319A1 (fr) 1981-10-07
JPS57500335A (cs) 1982-02-25
IL62424A0 (en) 1981-05-20
HU188657B (en) 1986-05-28
JPH0231081B2 (cs) 1990-07-11
CA1207759A (en) 1986-07-15
ES8201596A1 (es) 1982-01-16
DK172877B1 (da) 1999-09-06
DE3176086D1 (en) 1987-05-14
IL62424A (en) 1984-12-31
DK511381A (da) 1981-11-18
PL135948B1 (en) 1986-01-31
UA5934A1 (uk) 1994-12-29
YU43008B (en) 1989-02-28
IE52951B1 (en) 1988-04-27
EP0037319B2 (fr) 1995-06-28
PL230237A1 (en) 1981-11-13
YU73681A (en) 1983-10-31
AR227417A1 (es) 1982-10-29
IE810632L (en) 1981-09-20
EP0037319B1 (fr) 1987-04-08
US4686288A (en) 1987-08-11
FR2478646B2 (cs) 1983-06-24
SU1658820A3 (ru) 1991-06-23
ES501130A0 (es) 1982-01-16
WO1981002737A1 (fr) 1981-10-01
CS222245B2 (en) 1983-05-27
FR2478646A2 (fr) 1981-09-25

Similar Documents

Publication Publication Date Title
DD157561A5 (de) Verfahren zur herstellung von mucopolysacchariden
DE2833898C2 (cs)
DE2850247A1 (de) Loesungen von glucosepolymergemischen mit niedrigem molekulargewicht und hohem kaloriengehalt, geeignet zur intravenoesen verabreichung
DE2944792C3 (de) Mucopolysaccharidfraktion, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3026180C2 (de) Rifamycin-SV-Salze von basischen Aminosäuren, Verfahren zu ihrer Herstellung und Arzneimittel zur intraartikulären Injektion bei der Bekämpfung von rheumatoider Arthritis
DE2417859C2 (de) Verfahren zur Herstellung von einfachen oder gemischten Heparinsalzen und diese enthaltende Arzneimittel
DE2834702C2 (cs)
DD144719A5 (de) Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
DE3019895C2 (cs)
DE1620629C3 (de) Verwendung eines Salzes von 2-Merkaptoäthansulf onsäure zur Herstellung von Mukolytica
DE3111056A1 (de) Verfahren zur gewinnung eines heilmittels mit wirkung bei arthritis und anderen krankheiten des osteolokomotorischen systems
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE938502C (de) Verfahren zur Herstellung einer kolloidalen Eisenzubereitung
DE3032606C2 (de) Polysaccharidderivat der Streptokinase, Verfahren zu dessen Herstellung und Anwendung
CH644133A5 (de) Oxydierte sterylglycosid-derivate und sie enthaltende pharmazeutische praeparate.
DE2625221C3 (de) Arzneimittel zur Kontrolle von Leberkrankeiten
DE2409650C3 (de) Verwendung wäßriger Lösung von menschlichem Serum-Haptoglobin bei der Bekämpfung von hämolytischen Nierenstörungen
CH640244A5 (en) Biologically active substance
DE1795327C3 (de) Verwendung von N-Acetyl-1-Hydroxyprolin
DE2246969C2 (de) Urokinase-Heparinat und dieses enthaltende Arzneimittel
DE2729903A1 (de) Antithrombosemittel
DE2635293A1 (de) Salzgemisch, insbesondere leicht assimilierbares arzneimittelgemisch mit erhoehter loeslichkeit, enthaltend kalziumsalze und/oder magnesiumsalze
DE2258495C3 (de) Polymerisationsprodukte des Kunitz-Inhibitors, Verfahren zur Herstellung dieser Produkte und diese Produkte enthaltende Arzneimittel
DE1296306B (de) Verfahren zur Gewinnung von Proteinstoffen mit biologischer Wirkung auf das Nervensystem
DE2038836B2 (de) Arzneimittel

Legal Events

Date Code Title Description
EP Request for examination under paragraph 12(1) filed
RPV Change in the person, the name or the address of the representative (searches according to art. 11 and 12 extension act)
VZ Disclaimer of patent (art. 11 and 12 extension act)